For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Cj Corporation

USPTO Granted Patents = 53

% Expired Patents = 47.2

CIPO Patents = 1

Trademarks = 90

Forward Citations = 199

Loading Chart...

Loading Chart...

187 inventors (with patents filed for the assignee):

Sung Hak Jung (13 out of 15 patents)

Myeong Yun Chae (10 out of 11 patents)

Kyu Jeong Yeon (9 out of 10 patents)

4. Young Hoon Kim (9 out of 52 patents)

5. Young Hoon Park (8 out of 22 patents)

6. Sang Wook Park (8 out of 29 patents)

7. Hyung Chul Ryu (8 out of 13 patents)

8. Ji Young Noh (8 out of 13 patents)

9. Hyun Jung Park (8 out of 9 patents)

10. Yong Sik Youn (8 out of 14 patents)

11. Jong Hoon Kim (8 out of 125 patents)

12. Dong Kwon Lim (8 out of 13 patents)

13. Il Hwan Cho (8 out of 17 patents)

14. Kwang Hyeg Lee (7 out of 7 patents)

15. Hae Tak Jin (7 out of 7 patents)

Core Competencies:

L-threonine

Triazole Derivatives

Riboflavin

Fermentation

Granulation

Pharmaceutical Compositions

Microorganisms

Organic Acid Salts

Nutrition

Food Packaging

Isothiazole Derivatives

Enzyme Production

53 patents: Sort by Forward Citations

1. D871252 - Trophy (2019-12-31),

2. 10115325 - System to display a flag and method to manufacture the system (2018-10-30),

3. 8916213 - Animal feed additives based on fermentation broth and production process thereof by granulation (2014-12-23),

4. 7745439 - Indene derivatives and process for the preparation thereof (2010-06-29),

5. 7741323 - Indene derivatives and process for the preparation thereof (2010-06-22),

6. 7566553 - [object Object] (2009-07-28),

7. 7488855 - Method of isolating 1,3-propanediol or 1,3-propanediol and 1,2-propanediol from solution containing 1,3-propanediol, 1,2-propanediol, glycerol, and glucose (2009-02-10),

8. 7473700 - 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same (2009-01-06),

9. 7432398 - Inorganic acid salts of sibutramine (2008-10-07),

10. 7429679 - Sulphonic acid salt of sibutramine (2008-09-30),

11. 7368266 - Method for L-threonine production (2008-05-06),

12. 7351560 - [object Object] (2008-04-01),

13. 7344858 - Glycosylated human granulocyte colony-stimulating factor (G-CSF) isoform (2008-03-18),

14. 7329780 - Method of preparing optically pure phenethylamine derivatives (2008-02-12),

15. 7314645 - Process for preparing nutritious cooked rice in aseptic package (2008-01-01),

Company Overview

Cj Corporation, headquartered in Seoul, South Korea, specializes in pharmaceutical chemistry with a focus on innovative biotechnological solutions. The company develops and manufactures a range of products, including L-threonine, triazole derivatives, and riboflavin, leveraging advanced fermentation and granulation techniques. Its expertise extends to pharmaceutical compositions and the utilization of microorganisms and organic acid salts, positioning Cj Corporation as a key player in the pharmaceutical industry, dedicated to enhancing health and wellness through scientific advancement.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

53 Patents

#120 in Seoul

#307 in South Korea

#13,348 in the World

Seoul, South Korea

Cj Corporation

Forward Citations = 199

187 inventors:

Sung Hak Jung (13 out of 15 patents)

Myeong Yun Chae (10 out of 11 patents)

Kyu Jeong Yeon (9 out of 10 patents)

4. Young Hoon Kim (9 out of 52 patents)

5. Young Hoon Park (8 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cj Corporation. Retrieved from https://idiyas.com/company/cj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…